CCR2 and breast cancer: This is consequential, because recruitment of CCR2 positive inflammatory Mø has been shown to occur preferentially in the lung pre-metastatic niche rather than in the primary mammary tumors of late-stage PyMT-induced breast cancers, which instead recruit CCR2-negative, CSF-1 dependent TAMs [8], [28].